Fig. 2From: Development of a risk-tailored approach and dashboard for efficient management and monitoring of investigator-initiated trialsDashboard screenshots of the Visits tab, sub-tab “Due visits” (Panel A), and the Safety management tab, sub-tab “Serious adverse events” (Panel B)Back to article page